SRIRAM H. BALASUBRAMANIAN M.D. NPI 1952366056

NPI Details

Sriram H. Balasubramanian, M.D. is an internal medicine in Bel Air, MD with 34 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Sriram H. Balasubramanian, M.D. NPI is 1952366056. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2021B EMMORTON ROAD
SUITE 210
BEL AIR, MD
ZIP 21015
Phone: (410) 569-1001
Fax: (410) 569-1569

The NPI 1952366056 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes (HCPCS:99458)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Automated urinalysis test (HCPCS:81003)
• Hemoglobin a1c level (HCPCS:83036)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes (HCPCS:G0396)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• X-ray of chest, 2 views (HCPCS:71046)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment (HCPCS:99453)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of drug or substance into vein (HCPCS:96374)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Complete ultrasound scan of abdomen (HCPCS:76700)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Administration and interpretation of patient-focused health risk assessment (HCPCS:96160)
• Assessment of emotional or behavioral problems (HCPCS:96127)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose (HCPCS:J7321)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• X-ray of knee, 3 views (HCPCS:73562)
• Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts (HCPCS:93978)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Rheumatoid factor level (HCPCS:86431)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use (HCPCS:91301)
• Uric acid level, blood (HCPCS:84550)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Sleep study including heart rate, breathing, and sleep time (HCPCS:95800)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Removal of impacted ear wax (HCPCS:69210)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Ultrasound scan of head and neck soft tissue (HCPCS:76536)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Magnesium level (HCPCS:83735)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• X-ray of ribs on side of body, minimum of 3 views (HCPCS:71101)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Injection, azithromycin, 500 mg (HCPCS:J0456)
• Heart rhythm recording of continous external ekg over 8-15 days (HCPCS:93246)
• Heart rhythm review and interpretation of continous external ekg over 8-15 days (HCPCS:93248)
• Complete ultrasound scan of pelvis (HCPCS:76856)
• X-ray of upper spine, 4-5 views (HCPCS:72050)
• Ultrasound study of arm or leg veins with compression and maneuvers (HCPCS:93970)
• Administration of vaccine (HCPCS:90471)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• X-ray of middle spine, 2 views (HCPCS:72070)
• Limited ultrasound scan of pelvis (HCPCS:76857)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 4/20/2006 and was last updated on 1/24/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.